Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles.
[congenital adrenal hyperplasia]
Objective
:
Steroid
21
-
hydroxylase
(
21
OH
)
,
encoded
by
CYP
21
A
2
,
is
the
major
autoantigen
in
autoimmune
Addison
's
disease
(
AAD
)
.
CYP
21
A
2
is
located
in
the
region
of
the
human
leukocyte
antigen
(
HLA
)
complex
on
chromosome
6
p
21
.
3
,
which
harbours
several
risk
alleles
for
AAD
.
The
objective
was
to
investigate
whether
CYP
21
A
2
gene
variants
confer
risk
of
AAD
independently
of
other
risk
alleles
in
the
HLA
loci
.
Design
:
DNA
samples
from
381
Norwegian
patients
with
AAD
and
340
healthy
controls
(
HC
)
previously
genotyped
for
the
HLA-A
,
-
B
,
-
DRB
1
,
and
-
DQB
1
and
MICA
loci
were
used
for
genotyping
of
CYP
21
A
2
.
Methods
:
Genotyping
of
CYP
21
A
2
was
performed
by
direct
sequencing
.
Linkage
of
CYP
21
A
2
to
the
HLA
loci
was
assessed
using
UNPHASED
version
3
.
0
.
10
and
PHASE
version
2
.
1
.
Results
:
Heterozygotes
of
the
single
nucleotide
polymorphisms
(
SNPs
)
rs
397515394
,
rs
6467
,
rs
6474
,
rs
76565726
and
rs
6473
were
detected
significantly
more
frequently
in
AAD
patients
compared
to
HC
(
P
<
0
.
005
)
,
but
all
SNPs
were
in
linkage
disequilibrium
(
LD
)
with
high
-risk
HLA-DRB
1
haplotypes
.
rs
6472
C
protected
against
AAD
(
Odds
ratio
=
0
.
15
,
95
%
confidence
interval
[
0
.
08
-
0
.
30
]
,
P
=
3
.
8
e-
10
)
.
This
SNP
was
not
in
LD
with
HLA
loci
(
P
=
0
.
02
)
,
but
did
not
increase
protection
when
considering
the
effect
of
HLA-DRB
1
alleles
.
Mutations
causing
congenital
adrenal
hyperplasia
were
found
in
heterozygosity
in
<
1
.
5
%
of
the
cases
in
both
groups
.
Conclusion
:
Genotypes
of
CYP
21
A
2
associated
with
AAD
are
in
LD
with
the
main
autoimmune
AAD
risk
loci
HLA-DRB
1
and
do
not
constitute
an
independent
genetic
susceptibility
locus
.
Diseases
Validation
Diseases presenting
"single nucleotide polymorphisms"
symptom
adrenomyeloneuropathy
alpha-thalassemia
benign recurrent intrahepatic cholestasis
congenital adrenal hyperplasia
dentin dysplasia
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
familial hypocalciuric hypercalcemia
hirschsprung disease
neonatal adrenoleukodystrophy
oculocutaneous albinism
oligodontia
pendred syndrome
primary effusion lymphoma
scrub typhus
triple a syndrome
waldenström macroglobulinemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom